Matches in Wikidata for { <http://www.wikidata.org/entity/Q93114302> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- Q93114302 description "article scientifique publié en 2019" @default.
- Q93114302 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q93114302 description "im Juni 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q93114302 description "scientific article published on 19 June 2019" @default.
- Q93114302 description "wetenschappelijk artikel" @default.
- Q93114302 description "наукова стаття, опублікована 19 червня 2019" @default.
- Q93114302 name "SAR optimization studies on modified salicylamides as a potential treatment for acute myeloid leukemia through inhibition of the CREB pathway" @default.
- Q93114302 name "SAR optimization studies on modified salicylamides as a potential treatment for acute myeloid leukemia through inhibition of the CREB pathway" @default.
- Q93114302 type Item @default.
- Q93114302 label "SAR optimization studies on modified salicylamides as a potential treatment for acute myeloid leukemia through inhibition of the CREB pathway" @default.
- Q93114302 label "SAR optimization studies on modified salicylamides as a potential treatment for acute myeloid leukemia through inhibition of the CREB pathway" @default.
- Q93114302 prefLabel "SAR optimization studies on modified salicylamides as a potential treatment for acute myeloid leukemia through inhibition of the CREB pathway" @default.
- Q93114302 prefLabel "SAR optimization studies on modified salicylamides as a potential treatment for acute myeloid leukemia through inhibition of the CREB pathway" @default.
- Q93114302 P1433 Q93114302-36707A0D-96CF-4836-BFAF-BC0FD1744845 @default.
- Q93114302 P1476 Q93114302-CF2B8F77-0F74-482E-9E7F-52D6DDBB0DD1 @default.
- Q93114302 P2093 Q93114302-005C0B6C-26A8-4095-A5D9-117F393947D5 @default.
- Q93114302 P2093 Q93114302-2663C61D-EAC7-4A4F-822C-5CDEC9DB18E2 @default.
- Q93114302 P2093 Q93114302-3B198479-FDCA-49AF-879A-35002D218FE3 @default.
- Q93114302 P2093 Q93114302-3E45CCE3-3C52-472A-A09D-361E42C01773 @default.
- Q93114302 P2093 Q93114302-45643927-CBF0-4BB4-9D27-96EC49ADA981 @default.
- Q93114302 P2093 Q93114302-45C45EC1-8347-4AED-830F-0CB3D5213CB9 @default.
- Q93114302 P2093 Q93114302-45DE1B20-B834-4ECA-B42B-151E89B855FA @default.
- Q93114302 P2093 Q93114302-5F5335BD-D95D-442F-8641-2D4B00A0E36F @default.
- Q93114302 P2093 Q93114302-68644660-B6BA-4668-9AC7-AEF35084CB1D @default.
- Q93114302 P2093 Q93114302-7D05FF34-D176-4F60-A013-E145648EC1D8 @default.
- Q93114302 P2093 Q93114302-99A65247-23F7-4CC6-9C32-6CA17E42F75E @default.
- Q93114302 P2093 Q93114302-9FDF6B86-DE84-4C25-B163-567F0B2EFEB7 @default.
- Q93114302 P2093 Q93114302-A6E5972B-510A-4469-9530-1725F1BE6DD5 @default.
- Q93114302 P2093 Q93114302-AC7F9CAC-D688-40AC-95CE-D2AEE997F54B @default.
- Q93114302 P2093 Q93114302-DCDB8FA9-2EDC-4AA8-905B-B1367BB6E758 @default.
- Q93114302 P304 Q93114302-49737210-AFE2-484C-B542-03FB32CFDD6A @default.
- Q93114302 P31 Q93114302-63FD7090-41F4-4937-9E37-57C26C61B6D0 @default.
- Q93114302 P356 Q93114302-8D458EC1-9D2B-4D00-BD85-1A2F50975747 @default.
- Q93114302 P433 Q93114302-A60D48A8-585C-4132-9C4D-A231D961B0E3 @default.
- Q93114302 P478 Q93114302-79966CFB-1FDD-4606-98B5-6A228CA4088C @default.
- Q93114302 P50 Q93114302-80F2964B-2B4F-44BF-84E6-7CEFEDC587B0 @default.
- Q93114302 P50 Q93114302-F48EC6F1-F7E9-40E9-999B-5BD8B47EC702 @default.
- Q93114302 P577 Q93114302-35B84137-8F8D-4F60-B443-CBCF44A7D54B @default.
- Q93114302 P698 Q93114302-E0171A15-1BF7-4A4B-A204-28BAF0D26500 @default.
- Q93114302 P921 Q93114302-3C47D2FB-D6FD-4AAD-899E-1588C378B10F @default.
- Q93114302 P356 J.BMCL.2019.06.023 @default.
- Q93114302 P698 31253529 @default.
- Q93114302 P1433 Q2709483 @default.
- Q93114302 P1476 "SAR optimization studies on modified salicylamides as a potential treatment for acute myeloid leukemia through inhibition of the CREB pathway" @default.
- Q93114302 P2093 "Andrew A Ng" @default.
- Q93114302 P2093 "Corey W Liu" @default.
- Q93114302 P2093 "Garrett Potter" @default.
- Q93114302 P2093 "Hee-Don Chae" @default.
- Q93114302 P2093 "Jae Wook Lee" @default.
- Q93114302 P2093 "Jeffrey Edwards" @default.
- Q93114302 P2093 "Justin Chan" @default.
- Q93114302 P2093 "Kathleen M Sakamoto" @default.
- Q93114302 P2093 "Mark C Capece" @default.
- Q93114302 P2093 "Mark Smith" @default.
- Q93114302 P2093 "Nick Cox" @default.
- Q93114302 P2093 "Samanta Capolicchio" @default.
- Q93114302 P2093 "Sharon Kam" @default.
- Q93114302 P2093 "Soichi Wakatsuki" @default.
- Q93114302 P2093 "Yvonne Lee" @default.
- Q93114302 P304 "2307-2315" @default.
- Q93114302 P31 Q13442814 @default.
- Q93114302 P356 "10.1016/J.BMCL.2019.06.023" @default.
- Q93114302 P433 "16" @default.
- Q93114302 P478 "29" @default.
- Q93114302 P50 Q49512140 @default.
- Q93114302 P50 Q93114298 @default.
- Q93114302 P577 "2019-06-19T00:00:00Z" @default.
- Q93114302 P698 "31253529" @default.
- Q93114302 P921 Q264118 @default.